Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma

Sun Yat-sen University800 enrolled

Overview

The purpose of this study is to determine the predictive value of a mRNA signature and liquid biopsy in patients with Diffuse Large B cell lymphoma.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

Diffuse Large B Cell Lymphoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * biopsy proved Diffuse Large B cell Lymphoma * newly diagnosed between 2000-01 and 2015-12 Exclusion Criteria: * patients with biopsy samples unavailable

Locations (1)

Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,

Guangzhou, China

RECRUITING

Outcomes

Primary Outcomes

Overall survival

Time frame: 5-years

Central Contacts

Qing qing Cai, MD

CONTACT

0086-20-87342823 caiqq@sysucc.org.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.